[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Kyntra Bio Inc (KYNB)

Kyntra Bio Inc (KYNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 27,972
  • Shares Outstanding, K 4,048
  • Annual Sales, $ 6,440 K
  • Annual Income, $ 183,450 K
  • EBIT $ -45 M
  • EBITDA $ -44 M
  • 60-Month Beta 1.01
  • Price/Sales 4.34
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 0.00% (unch)
  • Historical Volatility 34.16%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 0.00% on 06/11/26
  • IV Low 0.00% on 06/11/26
  • Expected Move (DTE 0) N/A (0.00%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 74
  • Volume Avg (30-Day) 21
  • Put/Call OI Ratio 0.13
  • Today's Open Interest 3,533
  • Open Int (30-Day) 3,542
  • Expected Range N/A to N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-3.27
  • Number of Estimates 2
  • High Estimate $-2.92
  • Low Estimate $-3.62
  • Prior Year $-3.38
  • Growth Rate Est. (year over year) +3.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.55 +2.29%
on 06/08/26
7.95 -15.72%
on 06/12/26
-0.13 (-1.90%)
since 05/18/26
3-Month
6.32 +6.01%
on 03/30/26
7.95 -15.72%
on 06/12/26
-0.35 (-4.96%)
since 03/18/26
52-Week
4.85 +38.14%
on 06/30/25
12.60 -46.83%
on 09/03/25
+1.54 (+29.84%)
since 06/18/25

Most Recent Stories

More News
Kyntra Bio Presents New Roxadustat Data on Improvements in Transfusion Independence Regardless of Ring Sideroblast Status in Patients with Anemia due to Lower-Risk Myelodysplastic Syndromes

In a post hoc analysis, patients treated with roxadustat showed a durable and clinically meaningful improvement in transfusion independence (TI) in patients with LR-MDS and high transfusion burden (HTB)...

KYNB : 6.70 (-3.04%)
Kyntra Bio: Q1 Earnings Snapshot

Kyntra Bio: Q1 Earnings Snapshot

KYNB : 6.70 (-3.04%)
Kyntra Bio Reports First Quarter 2026 Financial Results and Provides Business Update

Phase 2 monotherapy trial of FG-3246, a potential first-in-class antibody drug conjugate (ADC) targeting CD46, in metastatic castration-resistant prostate cancer (mCRPC) is progressing well with the interim...

KYNB : 6.70 (-3.04%)
Kyntra Bio to Report First Quarter 2026 Financial Results

SAN FRANCISCO, May 04, 2026 (GLOBE NEWSWIRE) -- Kyntra Bio, Inc. (Nasdaq: KYNB) will announce first quarter 2026 financial results on Monday, May 11 after market close. Kyntra Bio will also conduct a...

KYNB : 6.70 (-3.04%)
Replays from RedChip's Biotech Investor Conference Now Available

ORLANDO, FL / ACCESS Newswire / April 20, 2026 / RedChip Companies, an industry leader in investor relations, media, and research for microcap and small-cap companies, today announced that on-demand replays...

KYNB : 6.70 (-3.04%)
ANIX : 2.91 (+8.18%)
GTBP : 0.5140 (+11.98%)
RedChip's April 16 Virtual Investor Conference to Highlight Companies Driving the Next Wave of Biotech Innovation

ORLANDO, FL / ACCESS Newswire / April 10, 2026 / RedChip Companies, an industry leader in investor relations, media, and research for microcap and small-cap companies, today announced its upcoming virtual...

KYNB : 6.70 (-3.04%)
ANIX : 2.91 (+8.18%)
GTBP : 0.5140 (+11.98%)
Kyntra Bio to Present at the 25th Annual Needham Virtual Healthcare Conference

SAN FRANCISCO, April 08, 2026 (GLOBE NEWSWIRE) -- Kyntra Bio (Nasdaq: KYNB) today announced that the Company will present at the 25 th Annual Needham Virtual Healthcare Conference being held April...

KYNB : 6.70 (-3.04%)
Kyntra Bio: Q4 Earnings Snapshot

Kyntra Bio: Q4 Earnings Snapshot

KYNB : 6.70 (-3.04%)
Kyntra Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Phase 2 monotherapy trial of FG-3246, a potential first-in-class antibody drug conjugate (ADC) targeting CD46, in metastatic castration-resistant prostate cancer (mCRPC) is actively enrolling and remains...

KYNB : 6.70 (-3.04%)
Kyntra Bio to Report Fourth Quarter and Full Year 2025 Financial Results

SAN FRANCISCO, March 09, 2026 (GLOBE NEWSWIRE) -- Kyntra Bio (Nasdaq: KYNB), formerly FibroGen (Nasdaq: FGEN), will announce fourth quarter and full year 2025 financial results on Monday, March 16 after...

KYNB : 6.70 (-3.04%)

Business Summary

Kyntra Bio is a biopharmaceutical company focused on development of novel therapies in oncology and rare disease. Kyntra Bio, formerly known as FibroGen Inc., is based in SAN FRANCISCO.

See More

Key Turning Points

3rd Resistance Point 7.01
2nd Resistance Point 6.93
1st Resistance Point 6.82
Last Price 6.70
1st Support Level 6.62
2nd Support Level 6.54
3rd Support Level 6.42

See More

52-Week High 12.60
Fibonacci 61.8% 9.64
Fibonacci 50% 8.73
Fibonacci 38.2% 7.81
Last Price 6.70
52-Week Low 4.85

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.